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function, is highly prevalent, and imposes a large economic
burden worldwide. Renal fibrosis is the final common
pathway leading to CKD regardless of the initial insult. The
extent of renal fibrosis is highly correlated with the severity
of CKD. Understanding the pathophysiology of renal fibrosis
is of paramount importance.
Microscopically, four major pathological features are
seen in renal fibrosis: interstitial extracellular matrix (ECM)
deposition, cellular infiltration, tubular atrophy, and
capillary rarefaction.1,2 ECM deposition may be the most
prominent feature. The major components identified in
fibrotic ECM are collagen type I, collagen type III, and
fibronectin. In our previous study, we showed that renal
pericytes/perivascular fibroblasts are the major source of
scar-producing myofibroblasts in the progressively fibrotic
kidney.1 Many argue that damaged tubular epithelial cells
undergo epithelial-to-mesenchymal transition (EMT) and
are responsible for renal fibrosis. However, the phenome-
non of EMT was not observed in vivo in a robust model of
the genetic fate-tracing technique.1 In line with our find-
ings, pericytes have been identified as the major pro-
genitors of the scar tissue in many organs including the
central nervous system, colon, liver, and skin.1
Hypoxia-inducible factor (HIF) is a DNA-binding tran-
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oxygen labile a-subunit. Three types of a-subunit have been
discovered, namely HIF-1a, HIF-2a, and HIF-3a. The func-
tion of HIF-1a and HIF-2a is currently being intensively
investigated, while the role of HIF-3a is less well known.
Under normoxic conditions, oxygen stimulates hydroxyl-
ation of HIF-a by prolyl-hydroxylase domain (PHD) con-
taining enzymes. The hydroxylated HIF-a is recognized by
von Hippel-Lindau tumor suppressor protein (pVHL) and
subsequently ubiquitylated by the Elongin BC/Cul2/pVHL
ubiquitineligase complex. The ubiquitylated HIF-a is then
sent to the proteasome for degradation. Under hypoxic
conditions, the PHD-mediated hydroxylation of HIF-a is
inhibited. The stabilized HIF-a binds to HIF-b and together
they translocate into the nucleus, where the dimer binds to
hypoxia-responsive elements and induces enhanced tran-
scription of the target genes. Many target genes have been
implicated, including erythropoietin, vascular endothelial
cell growth factor (VEGF), heme oxygenase 1, tissue in-
hibitor of metalloproteinase, connective tissue growth
factor, and nitric oxide synthase.
The role of HIFs in CKD is obscure. Although some animal
studies showed beneficial effects of HIF activation in CKD,
others have yielded conflicting results. Possible explana-
tions for this discrepancy include the nature and duration
of the animal models as well as the methods for manipu-
lating HIF activity. Tanaka et al demonstrated that global
activation of HIFs by cobalt chloride can preserve peri-
tubular capillaries and reduce tubulointerstitial injury in
rats with renal mass reduction.3 However, Norman et al
demonstrated that hypoxia can increase the production of& Formosan Medical Association. All rights reserved.
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fibroblasts, and Higgins et al found that conditional
knockout of HIF-1a in proximal tubular epithelial cells of
transgenic mice receiving unilateral ureteral obstruction
(UUO) attenuates renal fibrosis.4,5 Schietke et al also found
that constitutional transgenic overexpression of HIF-2a in
distal tubular cells in mice results in renal fibrosis.6 How-
ever, these studies should be interpreted with caution. HIF-
1a and HIF-2amay possibly have different functions and the
result of activation of HIF may be cell type and context
dependent. As demonstrated by Rosenberger et al,7 upon
insult, HIF-1a is mainly expressed in renal cortical tubular
cells, medullary interstitial cells, and endothelial cells. The
expression of HIF-2a is discernible in renal cortical inter-
stitial cells and endothelial cells, with a distribution nearly
complementary to that of HIF-1a. Since pericytes represent
the majority of cortical interstitial fibroblasts which ex-
press HIF-2a rather than HIF-1a and pericyteemyofibroblast
transition is a novel target to attenuate renal fibrosis,1 we
propose that HIF-2a may be a better candidate than HIF-1a
for studying renal fibrosis and targeting pericytee
myofibroblast transition.
In normal kidney, pericytes maintain microvascular sta-
bility by secreting angiogenic factors for endothelial cells,
whereas pericyte-derived myofibroblasts lose their ability to
support microvascular stability by detaching from the normal
peri-endothelialpositionandevenbysecretingdysangiogenic
factors.1,2 Inhealthykidney,VEGF164 is theabundant isoform
that binds to the VEGF receptor on endothelial cells, but
during fibrotic injury pericyte-derived myofibroblasts switch
to synthesis of VEGF120 and VEGF188, isoforms known to lead
to dysangiogenesis in tumors and developing organs.2 It is
noteworthy that mice with genetic ablation of HIF-2a in
endothelial cells have shown impairedangiogenesis andblood
flow recovery after femoral artery ligation, as demonstrated
by Skuli et al.8 Given the close contact of pericytes and
endothelial cells and the crosstalk observed in previous
studies,1,2 we propose that HIF-2a plays an important role in
stabilizing the microvasculature by pericytes through alter-
ation of HIF-targeted angiogenic factors.
Since HIF serves as a master regulator that controls
adaptation to hypoxia by regulating the expression of genes
involved in angiogenesis, cell proliferation, immunity, and
ECM production, specific manipulation of HIFs in kidney
pericytes is needed to elucidate their detailed role in
healthy and diseased kidneys. It would be of great interest
to determine the role of HIF-2a, which is specificallyexpressed in pericytes, during the progression of renal
fibrosis. Taking advantage of the current advanced state of
mouse genetics, future study should be directed at the
conditional manipulation of HIF-2a in pericytes to clarify its
role in microvascular stability, inflammation, and ECM
production. As the mechanism of renal fibrosis is better
elucidated, it may be possible to halt or even reverse the
progression of renal fibrosis and CKD.Acknowledgments
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